Wells Fargo & Company Olema Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 45,661 shares of OLMA stock, worth $396,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,661

Previous 38,215 19.48%

Holding current value

$396,794

Previous $162,000 171.6%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$4.38 - $9.65 $32,613 - $71,853	7,446 Added 19.48%	45,661 $440,000
Q2 2025 Aug 14, 2025	BUY	$3.06 - $5.62 $45,826 - $84,165	14,976 Added 64.44%	38,215 $162,000
Q1 2025 May 13, 2025	BUY	$3.76 - $6.39 $1,932 - $3,284	514 Added 2.26%	23,239 $87,000
Q4 2024 Feb 12, 2025	BUY	$5.61 - $12.72 $33,424 - $75,785	5,958 Added 35.53%	22,725 $132,000
Q3 2024 Nov 13, 2024	BUY	$10.41 - $16.46 $4,757 - $7,522	457 Added 2.8%	16,767 $200,000

Q2 2024 Aug 13, 2024	BUY	$8.73 - $13.99 $57,879 - $92,753	6,630 Added 68.49%	16,310 $176,000
Q1 2024 May 10, 2024	BUY	$10.95 - $16.62 $13,380 - $20,309	1,222 Added 14.45%	9,680 $109,000
Q4 2023 Feb 09, 2024	BUY	$10.53 - $17.14 $18,248 - $29,703	1,733 Added 25.77%	8,458 $118,000
Q3 2023 Nov 13, 2023	SELL	$8.19 - $12.98 $29,221 - $46,312	-3,568 Reduced 34.66%	6,725 $83,000
Q2 2023 Aug 15, 2023	BUY	$3.22 - $9.65 $32,351 - $96,953	10,047 Added 4084.15%	10,293 $92,000
Q1 2023 May 12, 2023	BUY	$2.55 - $4.97 $10 - $19	4 Added 1.65%	246 $0
Q4 2022 Feb 13, 2023	BUY	$2.27 - $3.76 $13 - $22	6 Added 2.54%	242 $0
Q3 2022 Nov 14, 2022	BUY	$2.72 - $5.88 $97 - $211	36 Added 18.0%	236 $1,000
Q2 2022 Aug 12, 2022	SELL	$2.04 - $4.61 $3,239 - $7,320	-1,588 Reduced 88.81%	200 $1,000
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $34,360 - $83,295	-8,833 Reduced 83.17%	1,788 $8,000
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $86,327 - $302,984	9,866 Added 1306.75%	10,621 $99,000
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $17,334 - $22,748	755 New	755 $21,000
Q2 2021 Aug 16, 2021	SELL	$21.15 - $36.14 $81,194 - $138,741	-3,839 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$27.81 - $53.64 $105,928 - $204,314	3,809 Added 12696.67%	3,839 $128,000
Q4 2020 Feb 09, 2021	BUY	$37.09 - $54.5 $1,112 - $1,635	30 New	30 $1,000

Others Institutions Holding OLMA

# of Institutions

136

Shares Held

66M

Call Options Held

379K

Put Options Held

13K

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $351M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Olema Pharmaceuticals, Inc. Transaction History